东诚药业：目前氟[18F]化钠注射液暂无销售数据

Group 1 - The core point of the article is that Dongcheng Pharmaceutical has not yet disclosed sales data for its Sodium Fluoride Injection since its approval in May 2025, and future disclosures will be made in regular reports as required by regulations [1][2]. Group 2 - Investors inquired about the sales data, including volume, revenue contribution, and main sales regions/channels for the Sodium Fluoride Injection [1]. - Dongcheng Pharmaceutical confirmed that there is currently no available sales data for the product [1]. - The company advised investors to pay attention to future regular reports and announcements for updates on the product's operational status [1].